飲料添加劑藥物濫用檢測試紙
| 型 號： | |
| 報 價： |  |
飲料添加劑藥物濫用檢測試紙：食品添加劑是為改善食品色、香、味等品質(zhì)，以及為防腐和加工工藝的需要而加入食品中的人工合成或者天然物質(zhì)。
- 產(chǎn)品描述
飲料添加劑藥物濫用檢測試紙
廣州健侖生物科技有限公司
獨立包裝：BZO-BAR-COC--THC -MET--OPI-OXY-MDMA-PCP- AMP-XTC-MTD 或聯(lián)檢
MOB： 楊 ：
Opiate refers to any drug that is derived from the opium poppy, including the natural products, Morphine and codeine, and the semi-synthetic drugs such as heroin. Opioid is more general, referring to any drug that acts on the opioid receptor.
Opioid analgesics comprise a large group of substance which control pain by depressing the central nervous system. Large doses of Morphine can produce higher tolerance level and physiological dependency in users, and may lead to substance abuse. Morphine is excreted unmetabolized, and is also the major metabolic product of codeine and heroin. Morphine is detectable in the urine for several days after an opiate dose. 1
The OPI One Step Opiate Test Device is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Morphine in urine. The OPI One Step Opiate Test Device yields a positive result when the Morphine in urine exceeds 2000 ng/mL. This is the suggested screening cut-off for positive specimens set by the Substance Abuse and Mental Health Services Administration (SAMHSA, USA).
飲料添加劑藥物濫用檢測試紙
The OPI One Step Opiate Test Device is a lateral flow chromatographic immunoassay for the detection of Opiates in urine at a cut-off concentration of 2000 ng/mL.
This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Multi DOA Screen Panel are rapid chromatographic immunoassays for the qualitative and simultaneous detection of one to fourteen of the following drugs in a variety of combinations in human urine. The designed cutoff concentrations and direct calibrator for these drugs are as follows:
Parameter | Calibrator | Cut-off(ng/mL) |
THC | 11-nor-D9-THC-9-COOH | 50 ng/ml |
COC | Benzoylecgonine | 300 ng/ml |
PCP | Phencyclidine | 25 ng/ml |
OPI | Morphine | 2000 ng/ml |
MET | Methamphetamine | 1000 ng/ml |
MTD | Methadone | 300 ng/ml |
AMP | Amphetamine | 1000 ng/ml |
BAR | Secobarbital | 300 ng/ml |
BZO | Oxazepam | 300 ng/ml |
TCA | Nortriptyline | 1000 ng/ml |
MDMA | 3,4-Methylenediioxy-MET | 500 ng/ml |
BUP | BUP-3-D-Glucuronide | 10 ng/ml |
EDDP | EDDP | 100 ng/ml |
OPI/MOR | Morphine | 300 ng/ml |
KET | Ketamine | 1,000ng/ml |
TML | Cis-Tramadol | 100ng/ml |
OXY | Oxycodone | 100ng/ml |
PPX | Propoxyphene | 300ng/ml |
K2 | JWH-073/JWH-01 | 50 ng/ml |
FYL | * | 200 ng/ml |
COT | Cotinine | 200 ng/ml |
ALC | Alcohol |
|
添加掃一掃二維碼：
【公司名稱】 廣州健侖生物科技有限公司
【市場部】 楊永漢
【】
【騰訊 】
【公司地址】 廣州市清華科技園健新基地番禺石樓鎮(zhèn)健啟路63號二期2幢101-103室
企業(yè)文化
